Clinical Trials
-
A multicenter, randomized, blinded study to assess safety and efficacy of pasireotide LAR vs. octreotide LAR in patients with active acromegaly
Recruiting
-
A randomized, double-blind study to assess the safety and efficacy of different dose levels of Pasireotide (SOM230) s.c. over a 6 month treatment period in patients with de novo, persistent or recurrent Cushing's disease
Recruiting
-
Effects of Growth Hormone on Cognition and Cerebral Metabolism in Adults
Recruiting
-
Efficacy and Safety Study of CORLUX (mifepristone) in the Treatment of Endogenous Cushing’s Syndrome
Recruiting
-
PHASE III, OPEN-LABEL, MULTICENTER INTERNATIONAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN OCTREOTIDE IMPLANT VERSUS SANDOSTATIN LAR® DEPOT IN PATIENTS WITH ACROMEGALY
Recruiting
-
SAFETY AND BIOLOGICAL ACTIVITY OF A NEW PROLONGED RELEASE FORMULATION OF OCTREOTIDE ACETATE, C2L-OCT-01 PR, ADMINISTERED INTRAMUSCULARLY EVERY 4, 5 OR 6 WEEKS IN ACROMEGALIC PATIENTS
Recruiting
-
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Completed
-
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Completed
-
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
No longer recruiting
Navigation for This Section: Administration
Find a Researcher
Help